Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Standard BioTools Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
LAB
Nasdaq
3850
www.standardbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Standard BioTools Inc.
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- Feb 10th, 2026 5:00 am
Standard BioTools Completes Sale of SomaLogic to Illumina
- Jan 30th, 2026 7:09 am
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago
- Jan 24th, 2026 6:39 am
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
- Jan 8th, 2026 5:00 am
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses
- Dec 28th, 2025 6:17 am
Penny Stocks To Watch In December 2025
- Dec 1st, 2025 5:05 am
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
- Nov 19th, 2025 9:30 am
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
- Nov 10th, 2025 10:15 am
Standard BioTools (LAB): Losses Continue While Low Price-to-Sales Spurs Value Debate
- Nov 5th, 2025 4:16 pm
Standard BioTools: Q3 Earnings Snapshot
- Nov 4th, 2025 3:31 pm
Standard BioTools Reports Third Quarter 2025 Financial Results
- Nov 4th, 2025 2:05 pm
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
- Oct 21st, 2025 5:00 am
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
- Sep 3rd, 2025 7:15 am
Standard BioTools Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
- Aug 13th, 2025 4:42 am
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
- Aug 11th, 2025 5:00 pm
Standard BioTools: Q2 Earnings Snapshot
- Aug 11th, 2025 4:09 pm
Standard BioTools Reports Second Quarter 2025 Financial Results
- Aug 11th, 2025 2:01 pm
The past five years for Standard BioTools (NASDAQ:LAB) investors has not been profitable
- Aug 11th, 2025 6:22 am
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
- Aug 6th, 2025 5:00 am
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
- Jul 21st, 2025 5:00 am
Scroll